QA: Johnson Johnson in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000200406_2015_Johnson_Johnson.pdf

Logs

Graph

Absolute values for 0000200406, Johnson Johnson

  xvar xval
0 AssetsCurrent 59,311,000,000
1 IntangibleAssetsNetIncludingGoodwill 49,054,000,000
2 PropertyPlantAndEquipmentNet 16,126,000,000
3 remainder_Assets 6,628,000,000
4 LiabilitiesCurrent 25,085,000,000
5 LiabilitiesNoncurrent 23,156,000,000
6 remainder_Liabilities 13,126,000,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,951,993,139
9 ResearchAndDevelopmentExpense 8,490,772,066
10 remainder_Expenses 27,579,093,487
11 remainder_Revenues 74,342,301,344
12 remainder_NetIncome -55,229,897
13 remainder_ComprehensiveNetIncome 2,943,895,796
  yvar yval
0 Assets 131,119,000,000
1 Liabilities 61,367,000,000
2 Expenses 58,021,858,692
3 Revenues 74,342,301,344
4 StockholdersEquity 69,752,000,000
5 NetIncome 16,265,212,755
6 ComprehensiveNetIncome 17,737,160,653
7 BaseVar 163,924,642,864
8 EconomicCapitalRatiobeforeLimitedLiability 1.76
9 EconomicCapitalRatio 2.86

Edgar->Model Mapping

Feature Distribution

Change over Time